Moderna coronavirus vaccine begins phase 3 trial with 30,000 participants

Moderna coronavirus vaccine begins phase 3 trial with 30,000 participants

The Moderna vaccine phase three trial is underway with 30,000 people taking part. Half will receive the vaccine and the rest will get a placebo. Meg Oliver has the details.